CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 5 enrolled
Drug / intervention
Surgical debulking and Intrathoracic Hyperthermic Chemotherapyprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01163552
NCT01163552Phase 2Completed

Surgical Cytoreduction Followed by Intraoperative Intrathoracic Hyperthermic Chemotherapy Perfusion for the Management of Disseminated Pleural Malignancies

St. Luke's-Roosevelt Hospital Center·interventional·Posted Jul 15, 2010·Updated Jun 13, 2014

In Brief

A Phase 2 clinical trial evaluating Surgical debulking and Intrathoracic Hyperthermic Chemotherapy for Pleural Metastases and 6 related conditions. Completed, enrolled 5 participants across 1 site.

Detailed Summary

Cancers that have spread to the inner lining of the chest are classified as Stage IV and bear a poor prognosis. Surgery is rarely an option, with palliative chemotherapy and/or radiation therapy the only treatment options. This study intends to evaluate whether surgical removal of all visible tumor on the chest wall followed by bathing the chest cavity in heated chemotherapy solution will improve outcomes for these advanced cancers.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 15, 2010
Enrollment StartJun 1, 2010
Primary CompletionMay 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 16.0 years ago

Interventions

Surgical debulking and Intrathoracic Hyperthermic Chemotherapyprocedure

Surgical debulking of intrathoracic metastases will be performed, followed by perfusion of the chest with heated Cisplatin for 60 minutes.